BPC-157 Peptide Therapy
Understanding BPC-157
An educational overview of BPC-157, a synthetic peptide studied in early-stage research.
Important Information
BPC-157 is not FDA-approved and is not offered at Cienega Medical. This page is for general education only and is not medical advice.
What Is BPC-157?
BPC-157 is a synthetic peptide studied primarily in laboratory and animal (preclinical) research. Human clinical evidence is limited. It is not approved by the U.S. Food and Drug Administration for any medical use, and in 2023 the FDA classified it as a Category 2 bulk drug substance. This page is provided for general education only.
FAQ
Click on a question to see more
-
What is BPC-157?
BPC-157 is a synthetic peptide studied mainly in preclinical (laboratory and animal) research. Human clinical evidence is limited and no health benefits have been established.
-
Is BPC-157 FDA-approved?
No. BPC-157 is not approved by the FDA for any use. In 2023 the FDA classified it as a Category 2 bulk drug substance, and it is not legally available for this use.
-
Does Cienega Medical offer BPC-157?
No. Cienega Medical does not offer, sell, prescribe, or administer BPC-157. This page is provided for general educational purposes only.
Cared for by our 12-person Los Angeles medical team. Meet your provider →
Visit us near you in West Hollywood, Santa Monica, and Calabasas
In-person, physician-supervised care at all three Cienega Medical clinics.
